Duodopa (ABT-SLV187) is a first line therapy for advanced Parkinson's disease patients with severe motor fluctuations, when conventional oral therapy is not effective.
Type of Molecule
Small Molecule
Target
Dopamine
Region
Approved in US (Duopa), EU and Japan
| Potential Indication | Product Type | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Parkinson's | New Indication | Phase Approved Approved |